BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3022444)

  • 1. Monoclonal antibody to the Epstein-Barr virus receptor induces human B lymphocyte activation and differentiation.
    Nemerow GR; McNaughton ME; Cooper NR
    Trans Assoc Am Physicians; 1985; 98():290-300. PubMed ID: 3022444
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR; McNaughton ME; Cooper NR
    J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways of human B-lymphocyte activation blocked by B-cell specific monoclonal antibodies.
    Golay JT; Crawford DH
    Immunology; 1987 Oct; 62(2):279-84. PubMed ID: 2824347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
    Perkins S; Foung SK
    Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
    [No Abstract]   [Full Text] [Related]  

  • 5. Relative lack of Epstein Barr virus (EBV) receptors on B cells from persistently EBV seronegative adults.
    Gervais F; Wills A; Leyritz M; Lebrun A; Joncas JH
    J Immunol; 1981 Mar; 126(3):897-900. PubMed ID: 6257786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
    Tsuchiyama L; Kieran J; Boyle P; Wetzel GD
    Hum Antibodies; 1997; 8(1):43-7. PubMed ID: 9265505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of Epstein-Barr virus (EBV) receptors on B lymphocytes from certain patients with common varied agammaglobulinemia.
    Schwaber JF; Klein G; Ernberg I; Rosen A; Lazarus H; Rosen FS
    J Immunol; 1980 May; 124(5):2191-6. PubMed ID: 6245136
    [No Abstract]   [Full Text] [Related]  

  • 9. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
    Yokochi T; Holly RD; Clark EA
    J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cells under influence: transformation of B cells by Epstein-Barr virus.
    Küppers R
    Nat Rev Immunol; 2003 Oct; 3(10):801-12. PubMed ID: 14523386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
    Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment.
    Cooper NR; Moore MD; Nemerow GR
    Annu Rev Immunol; 1988; 6():85-113. PubMed ID: 2838050
    [No Abstract]   [Full Text] [Related]  

  • 13. Immortalization of human lymphocytes by Epstein-Barr virus.
    Miller G
    Yale J Biol Med; 1982; 55(3-4):305-10. PubMed ID: 6295007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus: exploiting the immune system.
    Thorley-Lawson DA
    Nat Rev Immunol; 2001 Oct; 1(1):75-82. PubMed ID: 11905817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
    Stuart AD; Stewart JP; Arrand JR; Mackett M
    Oncogene; 1995 Nov; 11(9):1711-9. PubMed ID: 7478598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus.
    Conley ME; Chan MA; Sigal NH
    J Immunol; 1987 Mar; 138(5):1403-7. PubMed ID: 3027178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human antibodies to cedar pollen secreted by human peripheral lymphocytes transformed by Epstein-Barr virus].
    Shinmoto H; Takahashi T; Shinmoto M
    Arerugi; 2004 Jan; 53(1):14-8. PubMed ID: 14762326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing faces of EBV research.
    Klein G; Klein E
    Prog Med Virol; 1984; 30():87-106. PubMed ID: 6087416
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of Epstein-Barr virus transformation for the production of human monoclonal antibodies.
    Roome AJ; Reading CL
    Exp Biol; 1984; 43(1):35-55. PubMed ID: 6099808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G; Magrath IT; Blaese RM
    J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.